Measures predictive autoantibodies, some of which can appear up to 10 years before clinical symptoms. Efficiently and economically assesses possible tissue damage to multiple organs of the body.
Clinical Use
Measure Predictive Antibodies, some of which can appear up to ten years before the clinical onset of disease
Economically and efficiently assess possible tissue damage to multiple organs of the body
Recommended for Patients Who
A diagnosed autoimmune disorder, as they commonly develop additional autoimmune conditions
Chronic increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders
Antigens Tested (IgG)
Thyroglobulin
Thyroid Peroxidase (TPO)
Antigens Tested (Autoantibody)
Islet Cell Antigen (IA-2)
Glutamic Acid Decarboxylase 65 (GAD 65)
Antigens Tested (IgG + IgA Combined)
Parietal Cell + ATPase
Intrinsic Factor
ASCA + ANCA
Tropomyosin
21 Hydroxylase (Adrenal Cortex)
Myocardial Peptide
Alpha-Myosin
Phospholipid
Platelet Glycoprotein
Ovary/Testis*
Fibulin
Collagen Complex
Arthritic Peptide
Osteocyte
Cytochrome P450 (Hepatocyte)
Myelin Basic Protein
Asialoganglioside
Alpha + Beta Tubulin
Cerebellar
Synapsin
* Ovary and Testis are tested together to avoid any confusion arising out of potential cross-reactivity.
CPT® CODE : 83516 (x24)
Potential Molecular Mechanisms Where Loss of Tolerance Exists